Curida Diatec
Diatec Monoclonals is a Norwegian-founded biotechnology company with over 25 years of experience in antibody production and conjugation. They focus on custom production of monoclonal antibodies, downstream processing, cell banking, recloning, and establishing new cell lines. Their facilities adhere to ISO 9001 and GMP standards, and they serve clients ranging from research institutions to pharmaceutical companies. The company is actively involved in R&D projects, expanding facilities, and collaborating with industry partners to advance biopharmaceutical manufacturing.
Industries
Nr. of Employees
small (1-50)
Products
Panel of leukocyte-marker monoclonal antibodies
Licensed monoclonal antibodies targeting human CD markers and other leukocyte markers for research and diagnostic use.
Monoclonal antibody against human C5b-9 (Terminal Complement Complex)
In vitro-produced hybridoma-derived monoclonal antibody specific for human C5b-9, intended for research and diagnostic applications.
Affinity-purified human IgE monoclonal antibody (highly purified)
Affinity-purified, fully human IgE produced in vitro from a monoclonal hybridoma, provided as a contamination-free source for research and assay development.
Panel of leukocyte-marker monoclonal antibodies
Licensed monoclonal antibodies targeting human CD markers and other leukocyte markers for research and diagnostic use.
Monoclonal antibody against human C5b-9 (Terminal Complement Complex)
In vitro-produced hybridoma-derived monoclonal antibody specific for human C5b-9, intended for research and diagnostic applications.
Affinity-purified human IgE monoclonal antibody (highly purified)
Affinity-purified, fully human IgE produced in vitro from a monoclonal hybridoma, provided as a contamination-free source for research and assay development.
Services
Contract manufacture of monoclonal antibodies at scales from milligrams to grams with options for GMP or ISO production, custom buffers, concentrations, vialing and labeling.
Recloning, optimisation and establishment of new production cell lines to increase productivity and stability.
Purification, vialing and conjugation of antibodies to enzymes or fluorescent probes.
GLP/ISO-standard QC assays including SDS-PAGE, ELISA, GPC-HPLC, flow cytometry, mycoplasma testing, isotyping and sterility/microbiology testing with Certificates of Analysis.
Production of primary and secondary cell banks and dual-site liquid-nitrogen storage for long-term preservation.
Customisable productions with options for raw material, culturing media, supplements and specifications on buffer, concentration and labeling.
Contract manufacture of monoclonal antibodies at scales from milligrams to grams with options for GMP or ISO production, custom buffers, concentrations, vialing and labeling.
Recloning, optimisation and establishment of new production cell lines to increase productivity and stability.
Purification, vialing and conjugation of antibodies to enzymes or fluorescent probes.
GLP/ISO-standard QC assays including SDS-PAGE, ELISA, GPC-HPLC, flow cytometry, mycoplasma testing, isotyping and sterility/microbiology testing with Certificates of Analysis.
Production of primary and secondary cell banks and dual-site liquid-nitrogen storage for long-term preservation.
Customisable productions with options for raw material, culturing media, supplements and specifications on buffer, concentration and labeling.
Expertise Areas
- Monoclonal antibody production
- Cell line development and banking
- Downstream processing and conjugation
- Quality control and GLP/GMP compliance
Key Technologies
- Hollow-fiber bioreactor platforms
- Flask-based bioreactor production
- Automated robotics for cell culture workflows
- Bioprocess metabolite sensors (flow-cell integration)
News & Updates
Press release, April 2024. Curida Holding AS announced a significant growth investment from Signet Healthcare Partners and other shareholders, enabling expansion and growth.
In 2019, the Norwegian Life Science Cluster was included in the Arena program, promoting innovation through collaboration. Diatec celebrated this achievement.
Diatec is seeking biosensors to quantify key metabolites like glucose and glutamine in cell culture supernatants for automated antibody manufacturing.
Torbjørn Røe Isaksen visited Diatec to discuss biotech industry growth, technology, and collaboration with the Norwegian Research Council.
Diatec sponsored the 45th Annual Meeting of the Scandinavian Society of Immunology in Geilo, Norway, promoting immunological research.
In 2019, the Norwegian Life Science Cluster was included in the Arena program, promoting innovation through collaboration. Diatec celebrated this achievement.
Press release, April 2024. Curida Holding AS announced a significant growth investment from Signet Healthcare Partners and other shareholders, enabling expansion and growth.
In 2019, the Norwegian Life Science Cluster was included in the Arena program, promoting innovation through collaboration. Diatec celebrated this achievement.
Diatec is seeking biosensors to quantify key metabolites like glucose and glutamine in cell culture supernatants for automated antibody manufacturing.
Torbjørn Røe Isaksen visited Diatec to discuss biotech industry growth, technology, and collaboration with the Norwegian Research Council.
Diatec sponsored the 45th Annual Meeting of the Scandinavian Society of Immunology in Geilo, Norway, promoting immunological research.
In 2019, the Norwegian Life Science Cluster was included in the Arena program, promoting innovation through collaboration. Diatec celebrated this achievement.